 "Mankind Pharma’s Bold Move: Financing Rs 13,630 Crore Acquisition Amidst Debt")
Mankind Pharma’s Bold Move: Financing Rs 13,630 Crore Acquisition Amidst Debt
Mankind Pharma, India’s fourth-largest pharmaceutical company, plans to raise over Rs 9,000 crore through non-convertible debentures and short-term commercial paper to fund its Rs 13,630 crore acquisition of Bharat Serums and Vaccines Ltd. The company expects an average borrowing cost of about 8.5 percent. This acquisition will significantly enhance Mankind’s position in the gynaecology-fertility Market, ...
